INDICATIONS FOR USE
United States and Hong Kong
The AquaBeam ® Robotic System is intended for the resection and removal of prostate tissue in males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia.
Rest of World
The AquaBeam Robotic System is intended for the resection and removal of prostate tissue in males suffering from lower urinary tract symptoms.
IMPORTANT SAFETY INFORMATION
All surgical treatments have inherent and associated side effects. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. No claim is made that the AquaBeam® Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.
As with any surgical urologic procedure, potential perioperative risks of the Aquablation procedure may include:
- Anesthesia risk
- Bladder or prostate capsule perforation
- Bladder neck contracture
- Penile or pelvic pain
- TUR syndrome
- Electric shock/burn
- Urethral damage causing false passage or stricture
- Rectal incontinence / perforation
- Sexual dysfunction, including ejaculatory and erectile dysfunction
- Incontinence or overactive bladder
- Urinary Retention